Fresenius SE & Co. KGaA (ETR:FRE)
43.69
-0.81 (-1.82%)
At close: Mar 20, 2026
Fresenius SE & Co. KGaA Revenue
Fresenius SE & Co. KGaA had revenue of 5.96B EUR in the quarter ending December 31, 2025, with 5.88% growth. This brings the company's revenue in the last twelve months to 22.45B, up 4.49% year-over-year. In the year 2024, Fresenius SE & Co. KGaA had annual revenue of 21.83B with 3.64% growth.
Revenue (ttm)
22.45B
Revenue Growth
+4.49%
P/S Ratio
1.10
Revenue / Employee
126.55K
Employees
177,356
Market Cap
24.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21.83B | 766.00M | 3.64% |
| Dec 31, 2023 | 21.07B | -465.00M | -2.16% |
| Dec 31, 2022 | 21.53B | -15.99B | -42.61% |
| Dec 31, 2021 | 37.52B | 1.24B | 3.43% |
| Dec 31, 2020 | 36.28B | 868.00M | 2.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.58B |
| Siemens Healthineers AG | 23.30B |
| Merck KGaA | 21.10B |
| Fresenius Medical Care AG | 19.63B |
| Sartorius Aktiengesellschaft | 3.54B |
| Redcare Pharmacy NV | 2.94B |
| Fielmann Group AG | 2.42B |
| Carl Zeiss Meditec AG | 2.20B |
Fresenius SE & Co. KGaA News
- 5 days ago - EQS-DD: Fresenius SE & Co. KGaA: Sara Hennicken, buy - Wallstreet:Online
- 6 days ago - Glenmark Pharmaceuticals to launch Potassium Phosphates Injection in March 2026 - Business Upturn
- 16 days ago - EQS-DD: Fresenius SE & Co. KGaA: Michael Sen, buy - Wallstreet:Online
- 19 days ago - EQS-PVR: Fresenius SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 24 days ago - Fresenius SE & Co KGaA (FSNUY) Full Year 2025 Earnings Call Highlights: Strong Organic ... - GuruFocus
- 24 days ago - Full Year 2025 Fresenius SE & Co KGaA Earnings Call Transcript - GuruFocus
- 25 days ago - Fresenius SE & Co. (FSNUF) Reports Strong FY Core EPS Growth - GuruFocus
- 11 months ago - Fresenius posts profit beat in first quarter, confirms outlook - Reuters